Functional disability progressed more rapidly in postmenopausal compared with premenopausal women with rheumatoid arthritis.
Researchers compared patient-physician discordance in global assessment in patients with osteoarthritis vs patients with rheumatoid arthritis seen in routine care.
The safety of switching from reference rituximab to the rituximab biosimilar was comparable to continuation of reference rituximab.
Data highlight a lack of consideration of personal and environmental factors when studying the effects of RA on hand function.
Rheumatoid arthritis is associated with an increased occurrence of autoimmune thyroid disease, indicated by an increased risk of developing autoimmune thyroid disease before RA diagnosis.
Researchers assessed the risk for peripheral neuropathy with TNFi in patients with rheumatic diseases.
The FDA's approval was supported by data from analytical, preclinical, and clinical research showing that Hyrimoz matched the reference product's safety, efficacy, and quality.
Patients with rheumatoid arthritis or psoriatic arthritis have a low influenza vaccination rate, despite the recommendation from the CDC to be vaccinated annually.
Peficitinib significantly reduced symptoms in patients with rheumatoid arthritis and demonstrated tolerability and safety.
JAK inhibitors and biologic DMARDs demonstrated better SF-36 Physical Component Summary and Mental Component Summary scores at 12 weeks.
Data from the PRECISION trial were used to develop and validate a clinical risk score for NSAID toxicity in OA and RA.
Meeting the US Department of Health and Human Services guidelines for physical activity appears to be protective against worsening concentration and word retrieval in patients with rheumatoid arthritis.
Researchers examined predictors of persistent disease activity during the first year of rheumatoid arthritis treatment in men and women.
The use of triple therapy is infrequent in patients with rheumatoid arthritis in the United States.
Terence Rooney, MD, senior medical director, Lilly Bio-Medicines, discusses updated baricitinib safety data presented at ACR/ARHP 2018.
Treatment with filgotinib over 24 weeks resulted in significant improvements in the signs and symptoms of RA among patients with inadequate response or intolerance to biologic DMARDs.
A reduction in CVD risk was found with concomitant methotrexate and bDMARD use for rheumatoid arthritis.
Although the incidence rate of venous thromboembolism was numerically higher in patients treated with tofacitinib vs TNF inhibitors, the risk was not statistically significant.
The efficacy, safety, and immunogenicity of the infliximab biosimilar and the infliximab reference product were comparable from 54 to 78 weeks.
Patients treated with JAK inhibitors for rheumatoid arthritis may be less likely to have low disease activity if they are obese compared with those who are overweight.
Abatacept reduced the risk for diabetes in patients with rheumatoid arthritis.
A high-dose trivalent vaccine may enhance antibody production against influenza in people with RA.
Upadacitinib resulted in greater improvements in rheumatoid arthritis signs and symptoms compared with placebo and adalimumab.
Real-time patient input about treatment satisfaction can improve management strategies in patients with rheumatoid arthritis.
Tofacitinib extended release has comparable clinical efficacy to tofacitinib administered twice daily.
Initiation of DMARD therapy within 6 months of symptom onset was associated with greater reduction in RA disease activity compared with later initiation.
Intra-articular Steroid Injections With Tofacitinib Effective for Early RA With Rapid Radiographic ProgressionOctober 21, 2018
The results support combination therapy with intra-articular steroid injections and tofacitinib to achieve clinical and radiographic remission in patients with early rapid radiographic progression RA.
Data from the CDC show that the prevalence of anxiety and depression is higher among adults with arthritis compared with the general population.
Osteoarthritis was the most common form of arthritis in patients with diabetes but rheumatoid arthritis had the most pronounced association with diabetes.
Anti-TNF-α therapy has a beneficial effect on the metabolism of proteoglycans and glycosaminoglycans tissue in women with rheumatoid arthritis.
Rheumatology Advisor Articles
- 5-Step Guide to Activity Tracker Use for Patients With Rheumatic Diseases
- Gout Associated With Worse Outcomes in Obstructive Coronary Artery Disease
- Filgotinib Effective for Treatment of Active Psoriatic Arthritis
- Standard Set of Outcomes Developed for Value-Based Health Care in Inflammatory Arthritis
- Clinically Meaningful Improvement in Rheumatoid Arthritis Assessed With RAPID-3
- Circadian Rhythm in Rheumatoid Arthritis: Using Chronotherapy to Improve Outcomes
- Transcutaneous Electrical Nerve Stimulation Reduces Pain, Fatigue in Fibromyalgia
- Aspirin, Anticoagulants Similarly Prevent VTE After TKA
- Study: Cold Weather Joint Pain and Other Weather-Related Pain
- Increased Opioid Prescribing Linked to Chronic Usage in Patients With RA
- Treatment Retention Rates Lower in Patients Switching From Originator to Biosimilar Etanercept
- Climate Change Expected to Lead to Rise in Lyme Disease
- Red Cell Distribution Width Linked to Cardiovascular Disease Risk Factors in Spondyloarthritis
- Higher Biologic Drug Survival in JIA With Younger Age at Treatment Initiation
- Enough Is Enough? When Health Metrics Shift From Useful to Too Much